ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.090
-0.030 (-1.42%)
Dec 5, 2025, 4:00 PM EST - Market closed
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $220.17 million as of December 5, 2025. Its market cap has decreased by -28.40% in one year.
Market Cap
220.17M
Enterprise Value
114.11M
1-Year Change
-28.40%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $220.17M, a decrease of -28.70%. That is a compound annual growth rate of -2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 228.30M | 2.24% |
| Dec 31, 2024 | 223.30M | 33.87% |
| Dec 29, 2023 | 166.80M | -39.78% |
| Dec 30, 2022 | 277.00M | -53.81% |
| Dec 31, 2021 | 599.70M | 164.07% |
| Dec 31, 2020 | 227.10M | -46.89% |
| Dec 31, 2019 | 427.60M | -15.11% |
| Dec 31, 2018 | 503.70M | 568.92% |
| Dec 29, 2017 | 75.30M | -34.18% |
| Dec 30, 2016 | 114.40M | -43.53% |
| Dec 31, 2015 | 202.60M | -55.40% |
| Dec 31, 2014 | 454.30M | 47.12% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |